Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6785157 | 0.93 | F10 (0.79) | F10F2 | |
| SCHEMBL6785944 | 0.91 | F10 (0.83) | F10F2 | |
| SCHEMBL6788473 | 0.89 | F10 (0.82) | F10F2 | |
| SCHEMBL5819494 | 0.89 | F10 (1.00) | F10F2 | |
| SCHEMBL5794808 | 0.88 | F10 (0.77) | F10F2 | |
| SCHEMBL6788889 | 0.88 | F10 (0.86) | F10F2 | |
| SCHEMBL6785463 | 0.88 | F10 (0.89) | F10F2 | |
| SCHEMBL6788192 | 0.87 | F10 (0.92) | F10F2 | |
| SCHEMBL5791468 | 0.86 | F10 (0.85) | F10F2 | |
| SCHEMBL6786316 | 0.86 | F10 (1.00) | F10F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030022916-A1 | 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-01-30 | — | — | US | claimed |
| US-6706730-B2 | ANTICOAGULANTS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-16 | — | — | US | disclosed |
| US-20030022916-A1 | 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-01-30 | — | — | US | disclosed |
| WO-2002085353-A9 | 1,4,5,6-TETRAHYDROPYRAZOLO-[3,4-C]-PYRIDIN-7-ONES AS FACTOR XA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030022916-A1 | 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors | SERPINC1, SERPINE1, F11 | F10 34/4885F2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.